Rheos Medicines Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:$60M
Industry:Biotech
Founded:2017
Lead Investor(s):Third Rock Ventures, LLC
Press
Claim your profile

City Ranking

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • Rheos Medicines's estimated annual revenue is currently $6.7M per year.
  • Rheos Medicines received $60.0M in venture funding in March 2018.
  • Rheos Medicines's estimated revenue per employee is $155,000
  • Rheos Medicines's total funding is $60M.

Employee Data

  • Rheos Medicines has 43 Employees.
  • Rheos Medicines grew their employee count by 23% last year.
  • Rheos Medicines currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Ohana Bioscienc...
$8.7M5660%N/A
Tango Therapeut...
$12.9M8338%N/A
Compass Therape...
$16.4M10614%N/A
Cell Signaling ...
$89.4M577N/AN/A
Momenta Pharmac...
N/A220N/AN/A
Emulate
$15.3M99-17%N/A
ArQule
N/A94N/AN/A
Hamilton Storag...
$17.2M1119%N/A
Alnylam Pharmac...
$74.9M127731%N/A
Transgenomic
N/A47N/AN/A
Missing a competitor? Contribute!?
Submit

Rheos Medicines is a biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease. Our approach targets the underlying cellular metabolism of immune cells in order to redirect the fate and function of specific cell types to treat immune-mediated disease. By simultaneously identifying new drug targets and characterizing biomarkers of disease, we are, for the first time, bringing precision to treatment of immune-mediated diseases. We have brought together leading scientists whose discoveries opened the field of immunometabolism, clinicians with a deep understanding of the heterogeneity of immune-mediated disease, and an experienced biotech leadership team. Rheos was founded by Third Rock Ventures and is located in Cambridge, MA. For more information, please visit www.rheosrx.com.

keywords:N/A

43

Number of Employees

$6.7M

Revenue (est)

1

Current Jobs

23%

Employee Growth %

$60M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Executive Contacts

NameTitleEmail
Jeff ReedSenior Director of Informatics, Data & IT
Michael MorrisonDirector
Edward DriggersChief Technology Officer
Kevin LewtasVice President Finance
Eric LarsonPrincipal Scientist, Structural Biology
Zankar DesaiLab Manager
Guillaume BarbeSenior Director and Head of Chemistry
Vivek KaimalDirector, Head of Bioinformatics and
Brian AlbrechtVP Drug Discovery
Kelli ArmstrongLaboratory Manager

Rheos Medicines News

09/01/2019 - As Apple (AAPL) Shares Rose, Holder Cleararc Capital Has Trimmed Its Stake; Medicines Co (MDCO) Holding Has Upped by Antipodean Advisors Llc

Antipodean Advisors Llc increased its stake in Medicines Co ... 22/03/2018 – Third Rock Ventures Launches Rheos Medicines with $60 Million ...

09/06/2018 - Rheos Medicines Appoints Sanjay Keswani as Chief ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Rheos Medicines, a biopharmaceutical company developing novel medicines that modulate ...

10/10/2018 - Rheos Medicines Expands Leadership Team with ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Rheos Medicines, a biopharmaceutical company developing novel medicines that modulate ...

Rheos Medicines Funding

DateAmountRoundLead InvestorsReference
2018-03-23$60.0MAThird Rock Ventures, LLCArticle

Rheos Medicines Executive Hires

DateNameTitleReference
2018-09-07Sanjay KeswaniCEOArticle